Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001034842-26-000015
Filing Date
2026-03-03
Accepted
2026-03-03 16:06:08
Documents
107
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20251231.htm   iXBRL 10-K 2281691
2 EX-10.9 rigl20251231-exx109.htm EX-10.9 130306
3 EX-23.1 rigl-20251231xexx231.htm EX-23.1 9590
4 EX-31.1 rigl-20251231xexx311.htm EX-31.1 9716
5 EX-31.2 rigl-20251231xexx312.htm EX-31.2 9766
6 EX-32.1 rigl-20251231xexx321.htm EX-32.1 7122
12 rigl-20251231_g1.jpg GRAPHIC 116982
13 rigl-20251231_g2.jpg GRAPHIC 43520
  Complete submission text file 0001034842-26-000015.txt   11671152

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rigl-20251231.xsd EX-101.SCH 80273
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rigl-20251231_cal.xml EX-101.CAL 107484
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rigl-20251231_def.xml EX-101.DEF 321667
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rigl-20251231_lab.xml EX-101.LAB 936030
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rigl-20251231_pre.xml EX-101.PRE 627431
110 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20251231_htm.xml XML 1608519
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 26713966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)